openPR Logo
Press release

Radiopharmaceuticals Market Share, Size, Key Players, Trends, Demand, Competitive Analysis And Regional Forecast To 2027

01-12-2022 08:49 AM CET | Health & Medicine

Press release from: Market Research Future - MRFR

Radiopharmaceuticals Market

Radiopharmaceuticals Market

The increasing use of radioisotopes in mainstream medical treatment is estimated to boost the Radiopharmaceuticals Market in 2020. The pharmaceutical reports are made by Market Research Future, which includes market options for development. A CAGR of 8.10 % is estimated to carve out income worth USD 15,060.87 Million by 2025.

The increase in the number of therapeutic and diagnostic applications is estimated to have a conducive effect on the radiopharmaceuticals market share in the approaching period. The improvement in the delivery system through pharmacies is estimated to boost the radiopharmaceuticals market in the years ahead. The surge in chronic diseases is estimated to further play a notable role in the radiopharmaceuticals market through the coming years.

Get Sample Report @

Segmental Analysis
The segmental study of the radiopharmaceuticals market is conducted on the basis of type, application, and region. Based on the type, the radiopharmaceuticals market has been split into diagnostics and therapeutics. The application basis of segmenting the radiopharmaceuticals market has been conducted on the basis of cardiology, oncology, neurology, and others. Based on the region, the radiopharmaceuticals market is segmented into Africa, Europe, the Americas, the Middle East, and the Asia Pacific.

Detailed Regional Analysis
The regional analysis of the radiopharmaceuticals market is segmented into Africa, Europe, the Americas, the Middle East, and the Asia Pacific. The Americas radiopharmaceuticals market is estimated to control the chief market portion due to the presence of a vast patient population suffering from chronic diseases like cancer, coronary disorders, and strokes, altering lifestyles, and growing research & development for operative and less significant side effects therapies. The investment for research in the region is on the rise, and the occurrence of an enormous patient pool and the existence of industrialized economies such as the UK, Germany, and France are anticipated to thrust the growth of the radiopharmaceuticals market. The Asia pacific market radiopharmaceutical companies are increasing their operations in nations such as Singapore, China, India, and Russia, due to the cost-efficiency in these regions. Moreover, the large group of geriatric inhabitants demanding invasive therapies for the treatment of the growing cases of cardiovascular diseases, neurological diseases, and others are estimated to promote the Asia Pacific region.

Competitive Analysis
The market is estimated to be further motivated by the policies that will be framed to create a conducive working atmosphere in the coming period. The tumultuous nature of global markets is currently estimated to create significant hindrances in the development of the market in the forecast period. The production technology and processes are estimated to undergo a considerable overhaul to be able to meet the expectations of the new reality in the business domains. The benefits of mergers and collaborations are likely to be more pronounced in this context as pooling in resources and capabilities can lead to the creation of a stronger competitive advantage for companies in the market. The inducement provided by governments is estimated to create a positive outlook for the development of the market in the impending period. The need for innovation and incorporation of more value in products is estimated to induce the global market constructively to expand in the forecast period.

The prominent companies in the radiopharmaceuticals market are Lantheus Medical Imaging, Inc., Novartis AG, BWX Technologies, Inc., Siemens Healthineers, IRE ELiT, NTP Radioisotopes SOC Ltd, JSC Isotope, GE Healthcare, Curium, Australian Nuclear Science and Technology Organization (ANSTO), and others.

Industry Updates:
Sep 2020 Scientists employed in an IAEA Coordinated Research Project (CRP) have advanced two novel nanoparticles that possess promise for a novel generation of nanosized radiopharmaceuticals, which might intensely advance early discovery and treatment of numerous forms of cancers.

Browse Complete Report Details @

More Related Report:
Tissue Transglutaminase Test Market @
Hospital beds Market @
Topical Corticosteroids Market @

Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiopharmaceuticals Market Share, Size, Key Players, Trends, Demand, Competitive Analysis And Regional Forecast To 2027 here

News-ID: 2524398 • Views: 288

More Releases from Market Research Future - MRFR

Low-Pressure Liquid Chromatography Market Report Growth, Size, Demand, Trends an …
Market Highlights According to MRFR analysis, the global low-pressure liquid chromatography market is expected to register a CAGR of ~3.6% from 2020 to 2027. The global low-pressure liquid chromatography market is driven by the expansion of research facilities across the globe, increasing government funding in the healthcare sector, and the rising population diagnosed with hereditary disorders such as Parkinson's disease, sickle cell disease, and Alzheimer's disease. In addition, increasing demand for DNA-based,
Emergency Medical Service Market Size, Share, Top Players, Demands, Overview, Co …
Overview: The report on the market for global emergency medical services is revealing opportunities that can take the market beyond an expected valuation of USD 32.95 billion by 2025 by noting a 6.9% CAGR over the forecast period encompassing 2019 to 2025. Market Research Future (MRFR) revealed that this market could benefit from increasing investment in the sector from government and private organizations, various mergers and collaborations, better technological support, and
Battery Analyzer Market 2022 Growth Factors, Applications, Regional Analysis, To …
Market Highlights The global battery analyzer market is expected to be valued at USD 546 million by 2026, with ~4% CAGR during the forecast period, 2020–2026. Battery Analyzer are used to measure the voltage, capacity, and other technical specifications of batteries. In 2019, Asia-Pacific dominated the global battery analyzer market share: MRFR The global battery tester market has been segmented into five regions, namely, Asia-Pacific, the Middle East & Africa, Europe, North America,
CNG Compressor Market Share, Growth Analysis with Industry Trends 2022, Emerging …
Market Research Future (MRFR) confirms in its new study that the global CNG compressors market 2020 can procure a growth rate of 5.0% between 2021 and 2027 (which is the review period). We will provide COVID-19 impact Analysis with the report. Growth Inducers and Key Barriers Apart from the OEMs like Ford, GM, Volvo, Fiat and Audi that offer light, medium, as well as heavy vehicles, the renowned players across the automotive

All 5 Releases

More Releases for Radiopharmaceuticals

Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029 The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors. Market Analysis and Size The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029. Gets a Sample Copy of the Nuclear
Diagnostic Radiopharmaceuticals Market 2021 | Detailed Report
According to Market Study Report, Diagnostic Radiopharmaceuticals Market provides a comprehensive analysis of the Diagnostic Radiopharmaceuticals Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of Diagnostic Radiopharmaceuticals Market @ The report provides a comprehensive analysis of
Global Radiopharmaceuticals Market 2017-2021
About Radiopharmaceuticals Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Global Radiopharmaceutical Market Overview 1.1 Current Market Scenario 1.2 Diagnostic & Therapeutic Radiopharmaceuticals 1.3 Global Radiopharmaceticals Clinical Pipeline Overview 2. Global Radiopharmaceuticals Market Dynamics 3. Radioisotopes Used in Radiopharmaceuticals 4. EMA Guidelines for Radiopharmaceuticals 4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products 4.2 Toxicological & Pharmacological Tests 4.3 Clinical Documentation 4.4 Radiation
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a